Boehringer Ingelheim International Gmbh v. Mr X Trading as Messrs Amar Medical Store & Ors.
Case brief
What is this about?
Consent/settlement decree, Delhi High Court, CS(COMM) 477/2022, order dated 24.02.2026 by Justice Tushar Rao Gedela; joint Order XXIII Rule 3 r/w Section 151 CPC application (I.A. 5104/2026) by plaintiff Boehringer Ingelheim International GmbH and defendant no. 4 (Mr X trading as Messrs Amar Medical Store); pharmaceutical trade marks JARDIANCE, JARDIANCE MET, TRAJENTA DUO, GLYXAMBI and trade dress/copyright infringement-counterfeiting suit; undertakings of non-challenge, no counterfeiting, recall, disclosure/co-operation; litigation costs INR 5,00,000/- via Lall & Sethi; plaintiff foregoes damages; permanent and mandatory injunction decree; suit decreed and disposed of with all pending applications; decree sheet directed.
What did the court decide?
Suit decreed in favour of the plaintiff in terms of the settlement with defendant no. 4: defendant no. 4 acknowledges the plaintiff's exclusive ownership of the trade marks JARDIANCE, JARDIANCE MET, TRAJENTA DUO, GLYXAMBI and of the copyrights/trade dress in the packaging and logos; undertakes never to challenge those rights; affirms non-manufacture and future abstention from manufacturing/procuring/selling counterfeit products under the marks; confirms recall of finished/unfinished counterfeit products and promotional materials; agrees to disclose information on counterfeiting sources and to co-operate with the plaintiff; agrees to pay INR 5,00,000/- as litigation costs through counsel Lall & Sethi prior to recording of the settlement; undertakes to suffer a decree of permanent and mandatory injunction; breach entitles the plaintiff to damages including liquidated damages and contempt action; the plaintiff foregoes its claim for damages; decree sheet to be drawn in terms of para 5(A) to (J).